LivingGLP1
Study S000964

Liraglutide for Low-responders After Bariatric Surgery

Registration

Registration
NCT04643301
Acronym
LIBAR
Study type
INTERVENTIONAL
Masking
NONE
Status
WITHDRAWN
Enrollment
0
Start
2020-12-21
Primary completion
2021-12-31
Lead sponsor
Zuyderland Medisch Centrum
Conditions
Obesity; Obesity, Morbid
Interventions
DRUG:Liraglutide Pen Injector
Results posted
FALSE
Individual participant data sharing
UNDECIDED

Registered primary outcomes

  • %TWL (%TWL) [6 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.